Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Han-Bum Park"'
Publikováno v:
Redox Biology, Vol 13, Iss C, Pp 470-476 (2017)
Heat shock protein 90 (HSP90) is a molecular chaperone that supports the stability of client proteins. The proteasome is one of the targets for cancer therapy, and studies are underway to use proteasome inhibitors as anti-cancer drugs. In this study,
Externí odkaz:
https://doaj.org/article/85ee6a706de24355b7dc85aa83e2f131
Publikováno v:
Stem cells and development. 30(21)
Mucin 1 (MUC1) is a transmembrane glycoprotein overexpressed in several cancer cells in which it regulates cell surface properties, tumor invasion, and cell death. Recently, we reported that MUC1-C, the C-terminal subunit of MUC1, is involved in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7538733d31f080b72cc11f97cc9311c1
https://pubmed.ncbi.nlm.nih.gov/34514853
https://pubmed.ncbi.nlm.nih.gov/34514853
Publikováno v:
Redox Biology, Vol 13, Iss C, Pp 470-476 (2017)
Redox Biology
Redox Biology
Heat shock protein 90 (HSP90) is a molecular chaperone that supports the stability of client proteins. The proteasome is one of the targets for cancer therapy, and studies are underway to use proteasome inhibitors as anti-cancer drugs. In this study,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10edfe922336763b77031bead576fc24
https://doi.org/10.1016/j.redox.2017.07.010
https://doi.org/10.1016/j.redox.2017.07.010
Autor:
Younghee Lee, Guang Wu, Dongbum Kim, Yong Sung Kim, Su In Lee, Hyung-Joo Kwon, Sangkyu Park, Ji-Hee Ha, Byoung Kwon Park, Jung Nam Kim, Han-Bum Park, Te Ha Kim, Avishekh Gautam
Publikováno v:
Oncotarget
// Guang Wu 1, * , Dongbum Kim 1, * , Byoung Kwon Park 1 , Sangkyu Park 2 , Ji-Hee Ha 3 , Te Ha Kim 4 , Avishekh Gautam 4 , Jung Nam Kim 4 , Su In Lee 4 , Han-Bum Park 2 , Yong-Sung Kim 3 , Hyung-Joo Kwon 1, 4 , Younghee Lee 2 1 Center for Medical Sc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c402dd0f0bf239b1bd7f21aeb59fb18d
https://doi.org/10.18632/oncotarget.13005
https://doi.org/10.18632/oncotarget.13005